International Archives of Otorhinolaryngology最新文献

{"title":"Characteristics of Tinnitus in Patients Affected by COVID-19: A Systematic Review.","authors":"Daniella Wuttke Doutrelepont, Carolina Pereira Fernandes, Luiza Silva Vernier, Marcia Salgado Machado","doi":"10.1055/s-0045-1802968","DOIUrl":"10.1055/s-0045-1802968","url":null,"abstract":"<p><strong>Introduction: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought up reports of an increase in new cases of tinnitus and changes in chronic and/or preexisting episodes. Nevertheless, there is no established data on the characteristics of tinnitus and its correlation with coronavirus disease 2019 (COVID-19).</p><p><strong>Objective: </strong>To analyze the characteristics of tinnitus in subjects affected by COVID-19 while detailing the correlation between these two factors.</p><p><strong>Data synthesis: </strong>We found 327 articles, 37 of which were selected: 11 cross-sectional studies, 4 case-control studies, 3 cohort studies, and 19 observational studies. The sum of the samples totaled 399,524 patients included in the present review. The prevalence of new tinnitus varied from 0.2% to 96.2%. Most articles provided incomplete information or were missing information. Systemic arterial hypertension was the most common underlying disease. Finally, we found a predominance of hearing loss and olfactory and taste disorders, followed by fever and cough.</p><p><strong>Conclusion: </strong>The prevalence of new tinnitus ranged from 0.2 to 96.2%, whereas the prevalence of preexisting tinnitus varied from 8 to 76.2%. It was not possible to satisfactorily assess the characteristics of tinnitus. Therefore, a direct correlation between tinnitus and COVID-19 could not be determined, as this symptom may be influenced by other factors.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-20"},"PeriodicalIF":1.1,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12367373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144952996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Regionalization of Health Care in Head and Neck Cancer: Concept and Considerations.","authors":"Sebastián Castro, Mario Tapia, Felipe Cardemil","doi":"10.1055/s-0045-1802574","DOIUrl":"10.1055/s-0045-1802574","url":null,"abstract":"<p><strong>Introduction: </strong>Head and neck cancer are rare and require complex medical and surgical management. Regionalization or centralization of care, defined as the concentration of patients with complex diseases from a specific area in institutions with more experienced and highly functional multidisciplinary teams, may be an alternative to achieve better oncologic outcomes.</p><p><strong>Objective: </strong>To systematize the current knowledge regarding the centralization of care in head and neck oncology and its consequences in the practice of related surgeries.</p><p><strong>Data synthesis: </strong>Currently, there is evidence that this strategy shows better oncologic outcomes in centers with greater volumes, greater adherence to evidence-based clinical guidelines and quality indicators, and a multidisciplinary team in charge of decision-making. The center in Ontario, Canada, is framed as an example of this strategy, achieving improved outcomes while maintaining a high level of quality.</p><p><strong>Conclusion: </strong>Although more high-quality studies are needed to support this strategy, we believe that the evidence already available is sufficient to consider it a valid option to improve the oncologic outcomes of patients.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-6"},"PeriodicalIF":1.1,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12367369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144953051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Music Training on Social, Behavioral, and Academic Skills of Children with Cochlear Implants from the School Teacher's Perspective.","authors":"Paula Martins-Said, Kátia de Freitas Alvarenga, Dagma Venturini Marques Abramides","doi":"10.1055/s-0045-1809646","DOIUrl":"10.1055/s-0045-1809646","url":null,"abstract":"<p><strong>Introduction: </strong>Music has been recognized as a therapeutic tool in auditory rehabilitation, promoting essential social and behavioral development in children with cochlear implants (CIs), as identified by the World Health Organization (WHO). Additionally, there is a lack of studies on the development of these skills in this context.</p><p><strong>Objective: </strong>To investigate the effect of music training on the development of social, behavioral, and academic skills in children with CIs from the schoolteacher's perspective.</p><p><strong>Methods: </strong>The present is an experimental study involving 10 children with CIs, aged between 6 and 10 years, who composed the experimental group. They had a semester of music training and were assessed through the Social Skills Rating System (SSRS) questionnaire at 4 different moments: 2 months before the beginning of the music training, at the beginning of the music training (first week of class), during the music training (3 months after the beginning), and at the end of the music training (6 months after the beginning). To compare the multiple SSRS assessments, we used the repeated measures analysis of variance (ANOVA) test and the Tukey test ( <i>p</i> ≤ 0.05).</p><p><strong>Results: </strong>The results showed a statistically significant improvement in social skills in terms of assertiveness, social resourcefulness, self-control, affectivity, cooperation, externalizing behavior problems, and academic competence.</p><p><strong>Conclusion: </strong>From the schoolteacher's perspective CI-using children who had music training experienced an improvement in their social and academic skills and behavioral problems.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-10"},"PeriodicalIF":1.1,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12367375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144953056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect of Oleuropein on the Treatment of Allergic Rhinitis.","authors":"Özge Çaglar Cil, Basak Büyük, Hüseyin Avni Eroglu, Hilal Sehitoglu","doi":"10.1055/s-0045-1809644","DOIUrl":"10.1055/s-0045-1809644","url":null,"abstract":"<p><strong>Introduction: </strong>Allergic rhinitis is a disease that negatively affects social and work life and sometimes does not respond to many treatments. Therefore, new treatments are needed. For the prevention and treatment of allergies, oleuropein has been emphasized, and positive results have been shown in the literature.</p><p><strong>Objective: </strong>To investigate the effects of general and topical oleuropein during the allergic rhinitis period and the histopathological changes in the nasal mucosa compared with steroid nasal sprays and control group in rats.</p><p><strong>Methods: </strong>We developed an experimental animal model with 44 rats divided into 6 groups. Except for the control group, the allergic rhinitis in the other five groups was created with ovalbumin. As treatment, saline was administered to group 3, steroids, to group 4, oleuropein, to group 5, and steroids and oleuropein were administered to group 6. The effects of the drugs were examined histopathologically and the levels of immunoglobulin E (IgE) in the blood were compared.</p><p><strong>Results: </strong>Considering the symptomatic findings in rats, we could observe that allergic rhinitis occurred. Based on the IgE levels and histopathological findings, we have statistically shown that oleuropein may be effective in treatment of allergy rhinitis.</p><p><strong>Conclusion: </strong>Oleuropein has been shown to be useful in the treatment of allergic rhinitis in an animal model, but further studies are needed before it is introduced into the medical practice.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-7"},"PeriodicalIF":1.1,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12367374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144953032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mucormycosis and Hearing: A Hospital-Based Study.","authors":"Monalisa Jati, Ripu Daman Arora, Ruuzeno Koutsu, Nitin M Nagarkar, Roshan Marandi, Kartik Agrawal","doi":"10.1055/s-0045-1802578","DOIUrl":"10.1055/s-0045-1802578","url":null,"abstract":"<p><p><b>Introduction</b>  Mucormycosis, a fungal infection with severe consequences, gained prominence during the coronavirus disease 2019 (COVID-19) pandemic. While significant efforts were made to understand the systemic implications of mucormycosis, its effect on the auditory system remains unexplored. <b>Objective</b>  This study aimed to investigate the auditory implications of mucormycosis through a comprehensive case-control study focusing on hearing loss and middle ear dysfunction. <b>Methods</b>  A total of 30 mucormycosis patients without prior auditory issues, and 30 age and gender-matched controls, underwent comprehensive hearing assessment, including pure-tone and immittance audiometry. Statistical analyses, including descriptive statistics, Mann-Whitney U test, Pearson chi-square test, and multiple logistic regression were performed to analyze the data. <b>Result</b>  Mucormycosis patients exhibited significantly higher auditory thresholds across all frequencies compared to controls ( <i>p</i>  < 0.05). Approximately half of these patients experienced some degree of hearing loss, predominantly mild. Immittance measurement showed a higher prevalence of abnormal tympanograms in mucormycosis patients, indicating middle ear dysfunction. Acoustic reflex was absent in half of the mucormycosis patients suggesting impaired auditory function. <b>Conclusion</b>  The present study revealed significant auditory health impacts of mucormycosis, finding a notable prevalence of hearing loss and middle ear dysfunction, which emphasizes the need for routine audiological evaluations and increased awareness of mucormycosis-related auditory issues. Despite the study's limitations, we identified potential risk factors for hearing impairment, suggesting a need for further large-scale studies to confirm these findings and understand the mechanisms. These insights aim to improve diagnosis, treatment, and prevention strategies for better clinical outcomes.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-7"},"PeriodicalIF":1.1,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144798996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is CPAP the Key to Reduce the Cardiovascular Risk in Patients with OSA?","authors":"Kiran Abraham-Aggarwal, Ashutosh Kacker","doi":"10.1055/s-0045-1801855","DOIUrl":"10.1055/s-0045-1801855","url":null,"abstract":"<p><p><b>Introduction</b>  Obstructive sleep apnea (OSA) is a prevalent condition often managed with continuous positive airway pressure (CPAP) treatment. There is an ongoing debate about the link between OSA and cardiovascular disease (CVD), but the existing evidence points toward an association. <b>Objective</b>  The present study aims to investigate whether CPAP is an effective strategy to reduce the risk of developing CVD risk among OSA patients. <b>Methods</b>  The literature search was conducted in collaboration with Weill Cornell Medical College librarians, and we identified the five most recent papers highlighting the correlation between CPAP treatment for OSA and CVD risk reduction. <b>Results</b>  Recent studies highlight the link between OSA and CVD, emphasizing the potential of the CPAP therapy to reduce the risks of developing CVD and the mortality associated with the condition. The analyses by Guo et al., Peker et al., Khan et al., and Wickwire et al., collectively involving thousands of patients across various study designs, including randomized clinical trials and retrospective cohort studies, consistently demonstrate that the CPAP treatment improves cardiovascular outcomes by lowering blood pressure, reducing sleepiness scores, and significantly decreasing the risk of serious CVD events, especially with consistent adherence to therapy. <b>Conclusion</b>  Although further studies are needed to confirm these findings among patients with consistent high compliance to the CPAP treatment, it remains reasonable to continue to prescribe CPAP as the first-line therapy for OSA due to its potential cardiovascular benefits and low associated risks.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-3"},"PeriodicalIF":1.1,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144798995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy, Safety, and Tolerability of Nasal Wash in Patients with Upper Respiratory Tract Diseases.","authors":"Ignazio La Mantia, Giovanna Stilo, Lepanto Lentini, Giorgio Ciprandi","doi":"10.1055/s-0045-1802576","DOIUrl":"10.1055/s-0045-1802576","url":null,"abstract":"<p><strong>Introduction: </strong>Nasal irrigation is a standard therapeutic option to clean the upper airways to remove abundant secretions and harmful substances. The Nasal Wash (SIIT, Milan, Italy) sinus irrigation system contains saline, bicarbonates, and polyethylene glycol.</p><p><strong>Objective: </strong>The present randomized controlled trial evaluated and compared the Nasal Wash hypertonic solution (NW-HS) with physiological saline (PS) in patients with nasal symptoms common to different upper airway diseases (infectious rhinitis, allergic rhinitis, and acute and chronic rhinosinusitis).</p><p><strong>Methods: </strong>The symptomatic patients were divided into two groups: those receiving NW-HS 1 to 2 times a day for 7 days and those receiving PS 1 to 2 times a day for 7 days. The primary efficacy measures included total nasal symptom score (TNSS) and the score on the verbal numeric rating scale (VNRS), assessed at baseline and during the treatment period.</p><p><strong>Results: </strong>In total, 70 patients participated in the trial: 35 were allocated to the NW-HS group and 35 to the PS group. In the NW-HS group, we observed a significant reduction in the TNSS over time, at rates higher than those of the PS group ( <i>p</i>  < 0.001), as well as a significant reduction in the VNRS score at all observation times, and also at rates higher than those of the PS group ( <i>p</i>  < 0.001). The safety was good for all patients.</p><p><strong>Conclusion: </strong>The present trial documented the efficacy and safety of NW-HS in the treatment of nasal symptoms common to upper respiratory tract disorders. Most of the beneficial effects appeared as early as three days after the beginning of the treatment. In addition, compared to PS, NW-HS showed impressive results; thus, it may represent a safe and valuable option in the non-pharmacological therapy for rhinitis.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-8"},"PeriodicalIF":1.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12307079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Timing Effect on Transient Evoked Otoacoustic Emission Referral Rates for Newborn Hearing Screening within and after 48 Hours of Birth.","authors":"Chuan Cheepcharoenrat, Amaraporn Rerkasem","doi":"10.1055/s-0045-1802580","DOIUrl":"10.1055/s-0045-1802580","url":null,"abstract":"<p><strong>Introduction: </strong>Newborn hearing screenings must be completed within 48 hours of birth.</p><p><strong>Objective: </strong>To determine the optimal timing for the first transient evoked otoacoustic emissions (TEOAEs) test by comparing the referral rates of infants tested between different time intervals.</p><p><strong>Methods: </strong>The present study was a retrospective cohort analysis of 2,713 newborns who underwent TEOAE tests between February 2021 and June 2022. The infants were categorized into groups according to the age at which they were tested: 12 to 24 hours, 25 to 36 hours, 37 to 48 hours, and > 48 hours. We compared referral rates across these groups.</p><p><strong>Results: </strong>The overall referral rate for infants tested within 48 hours from birth was 53%, significantly higher than the rate for those tested after 48 hours (46%, <i>p</i>  = 0.001). Notably, the highest referral rates were observed in neonates aged 25 to 36 hours. However, no significant difference in referral rates was found for high-risk infants tested either before or after 48 hours.</p><p><strong>Conclusion: </strong>Transient evoked otoacoustic emissions can be used to screen newborns' hearing within 48 hours, but the high referral rate suggests that Thailand should add automated auditory brainstem response (AABR) to its guidelines for hearing evaluation if newborns leave the hospital before 48 hours.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-8"},"PeriodicalIF":1.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12307080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and Clinical Factors Associated with Self-reported Smell and Taste Disorders in Older Adults Hospitalized with COVID-19.","authors":"Letícia de Carvalho Palhano Travassos, Hemílio Fernandes Campos Coelho, Assel Muratovna Shigayeva Ferreira, Leandro Pernambuco","doi":"10.1055/s-0045-1801854","DOIUrl":"10.1055/s-0045-1801854","url":null,"abstract":"<p><strong>Introduction: </strong>Complaints of smell and taste disorders are present in people with coronavirus disease 2019 (COVID-19), and they particularly impact older adults in their daily activities and quality of life. Understanding these disorders in this specific population is crucial due to the heightened susceptibility to decreased general health.</p><p><strong>Objective: </strong>To assess the prevalence and the factors associated with self-reported smell and taste disorders in older adults hospitalized with COVID-19.</p><p><strong>Methods: </strong>The present documentary and retrospective study used a dataset from the Paraíba State Department of Health based on individual record sheets of hospitalized people with severe acute respiratory syndrome (SARS), collected through a national form routinely applied in Brazilian hospitals. The complaints of smell and taste disorders were the dependent variables. The independent variables included the clinical outcomes and comorbidities. Data analysis involved descriptive statistics, the Fisher's exact test, and binary logistic regression. The confidence interval was 95%.</p><p><strong>Results: </strong>The sample comprised 5,014 older adults with a mean age of 74.50 ± 9.35 years, of both biological sexes, and most of them were admitted to the Intensive Care Unit (ICU), required non-invasive respiratory support, and experienced death. The prevalence of self-reported smell and taste disorders was 7.8% (95%CI = 7.2-8.8%) and 6.4% (95%CI = 5.6-7.1%) respectively. Smell disorders were less frequent among subjects admitted to the ICU and those who died, while taste disorders correlated with clinical outcomes such as fever, cough, sore throat, diarrhea, and comorbidities such as chronic neurological disease.</p><p><strong>Conclusion: </strong>Self-reported smell and taste disorders are present in almost 10% of older adults hospitalized with COVID-19, and they are associated with clinical outcomes and commorbities.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-10"},"PeriodicalIF":1.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12307078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immediate Effect of Neuromuscular Electrical Stimulation on Swallowing in Elderly People with Alzheimer's Dementia.","authors":"Eliene Giovanna Ribeiro, Cris Magna Dos Santos Oliveira, Aline Mansueto Mourão, Laélia Cristina Caseiro Vicente, Andréa Rodrigues Motta, Heitor Marques Honório, Giédre Berretin-Felix","doi":"10.1055/s-0045-1802579","DOIUrl":"10.1055/s-0045-1802579","url":null,"abstract":"<p><strong>Introduction: </strong>Dysphagia affects a significant number of patients with Alzheimer's dementia. Neuromuscular electrical stimulation may be a promising resource for dysphagia rehabilitation in this population.</p><p><strong>Objective: </strong>To investigate the immediate effects of neuromuscular electrical stimulation on hyoid bone displacement, pharyngeal transit time, and swallowing safety in elderly people with Alzheimer's dementia.</p><p><strong>Methods: </strong>We evaluated 30 elderly individuals with an average age of 82.79 years, regardless of the stage of dementia and with reduced hyolaryngeal elevation, using the Northwestern Dysphagia Patient Check Sheet. Neuromuscular electrical stimulation was performed at the sensory and motor levels in the submental region during videofluoroscopy, with food being offered in solid, pudding, and liquid consistencies, and in portions of 5 mL and 10 mL. We applied Analysis of variance and the Friedman test, adopting a significance level of < 5%.</p><p><strong>Results: </strong>The comparison between the sensory and motor levels of stimulation showed that there was a significant difference in hyoid bone displacement for the mushy consistency, with neuromuscular stimulation at the motor level. There was no difference in the application of stimuli for the other consistencies regarding hyoid bone displacement, pharyngeal transit time, and the penetration and aspiration scale.</p><p><strong>Conclusion: </strong>In elderly people with Alzheimer's dementia, neuromuscular electrical stimulation at the motor level generated a reduction in hyoid bone displacement during swallowing of food with pudding consistency, with no effects on pharyngeal transit time or swallowing safety.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"29 3","pages":"1-7"},"PeriodicalIF":1.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}